Filter

11 - 20 of 31 Results

  • Bird Flu Knowledge, Misleading Claims About Measles Prevention, and Health Content Restrictions — The Monitor

    Feature

    This volume features findings on beliefs about bird flu from KFF’s latest Tracking Poll on Health Information and Trust, as well as the false promotion of vitamin A as a preventative for measles. The Monitor also shares developments in content moderation on social media and how a study about mental health after gender-affirming care is misrepresented to make false claims about health care for transgender and non-binary people. Additionally, this volume explores when people prefer to use an AI chatbot, instead of a person, for health information.

  • COVID Vaccine Concerns and Claims About Ivermectin as Cancer Treatment — The Monitor

    Feature

    This volume covers recent claims about COVID vaccine safety after a new study describes a rare condition it calls “post-vaccination syndrome” (PVS). It also investigates the false claim that ivermectin can treat cancer and highlights the re-emergence of concerns online about Gardasil, and its alleged mortality rate.

  • U.S. Public Health

    Feature

    This Health Policy 101 chapter examines how public health is governed and delivered in the United States. The chapter includes explanations of key public health frameworks, services, capabilities and characteristics, how the public health system works in state, local and territorial governments, public health funding, workforce, and communication challenges in an era of declining trust and more.

  • Race-Based Vaccine Myths Spread Amid Measles Outbreaks — The Monitor

    Feature

    This volume discusses the spread of race-based vaccine myths and shifts in health communication from fact-checking to fostering open dialogue. It also explains common misconceptions about heart attack treatment and prevention, a new scientific journal that questions established science, and gaps in research standards for AI chatbots used in healthcare.

  • Skepticism Surrounding ADHD Diagnoses and Medication — The Monitor

    Feature

    This volume examines the impact of recent executive actions on federal health communication, along with concerns and stigmas surrounding ADHD diagnoses and treatments, including skepticism about pharmaceutical influence on medication promotion. It also explores distrust in food regulations following the FDA’s ban on Red Dye No. 3.

  • A Look at Federal Health Data Taken Offline

    Policy Watch

    This post looks at federal government databases with key health data that went offline on Jan. 31, 2025, including several related to HIV, some of which had returned by Feb. 2, 2025. It briefly describing the affected databases, which include widely used, large-scale national health surveys, indices, and data dashboards, that inform research, policy making, and media coverage about health care and public health.

  • Skepticism About Vaccines and Response to Bird Flu — The Monitor

    Feature

    This volume shares findings from the latest KFF Tracking Poll on Health Information and Trust, along with updates from Robert Kennedy Jr’s senate hearings. It also examines distrust in public health messaging about bird flu, motivations for sharing information online, and how fraudulent research can sometimes inform AI chatbot models.

  • A Few Thoughts After Twenty-Five Years Half In and Half Out of Journalism

    From Drew Altman

    In his latest column, KFF’s President and CEO Drew Altman dissects a few key challenges facing journalism, observed over decades overseeing KFF’s health journalism and media programs, including launching KFF Health News as its Founding Publisher in 2009.  He discusses the need for more coverage of state health policy decisions, how news can play a role in countering and not spreading misinformation, and the pros and cons of journalism awards, among others.

  • The Semi-Sad State of Consumer Protection In Health Care

    From Drew Altman

    In this column, KFF President and CEO Drew Altman explores the state of consumer protections in health care and explains why, even with consumer frustration clear, Congress is unlikely to pursue major new health insurance protections but there could be some modest steps.